Relationship between gestational transient thyrotoxicosis and vitamin D

Relationship between gestational transient thyrotoxicosis and vitamin D

Background/aim: Gestational transient thyrotoxicosis (GTT) is a transient, mild hyperthyroidism that occurs early in pregnancy and is due to human chorionic gonadotropin. There is no clear information about why only some pregnant women develop GTT. Previous papers stated that vitamin D plays a role in thyroid functions. We aimed to evaluate the relationship between vitamin D and GTT. Materials and methods: Fifty-three patients diagnosed with GTT at the 6th to 10th weeks of gestation were included in the study (GTT group). Thirty-five pregnant women with normal thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4) levels served as a control group. Vitamin D, TSH, fT3, and fT4 levels were followed during entire the pregnancy. Results: TSH levels had been normalized at the 20th week of gestation in all patients with GTT (mean TSH: 0.56 ± 0.2 µIU/mL). Vitamin D levels were significantly lower in the GTT group than the controls (11.1 ± 7.7 and 16.5 ± 0.5 ng/mL, respectively; P = 0.008). Conclusion: Pregnant women who are diagnosed with GTT should be evaluated for possible vitamin D deficiency.

___

  • 1. Alpgiray B (2006) Determination of the effects of the canola oil on the performance and 1. Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, ClearyGoldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P et al. Variability in thyroid-stimulating hormone suppression by human chorionic gonadotropin during early pregnancy. J Clin Endocrinol Metab 2008; 93: 3341-3347.
  • 2. Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J, Lejeune B. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990; 71: 276-287.
  • 3. Amino N, Kuro R, Tanizawa O, Tanaka F, Hayashi C, Kotani K,  Kawashima M,  Miyai K, Kumahara Y. Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin Exp Immunol 1978; 31: 30-37.
  • 4. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18: 404-433.
  • 5. Orito Y, Oku H, Kubota S, Amino N, Shimogaki K, Hata M, Manki K, Tanaka Y, Sugino S, Ueta M et al. Thyroid function in early pregnancy in Japanese healthy women: relation to urinary iodine excretion, emesis, and fetal and child development. J Clin Endocrinol Metab 2009; 94: 1683-1688.
  • 6. Yeo CP, Khoo DH, Eng PH, Tan HK, Yo SL, Jacob E. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol 2001; 55: 391-398.
  • 7. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007; 66: 1137-1142.
  • 8. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579-2585.
  • 9. Jordan SC, Toyoda M, Prehn J, Lemire JM, Sakai R, Adams JS. 1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cells. Mol Immunol 1989; 26: 979-984.
  • 10. Skaaby T, Husemoen LL, Thuesen BH, Linneberg A. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease. Endocrine 2015; 50: 231-238.
  • 11. Juonala M, Voipio A, Pahkala K, Viikari JSA, Mikkilä V, Kähönen M, Hutri-Kähönen N, Jula A, Burgner D, Sabin MA et al. Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. J Clin Endocrinol Metab 2015; 100: 1469-1476.
  • 12. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266- 281.
  • 13. Sar M, Stumpf WE, DeLuca HF. Thyrotropes in the pituitary are target cells for 1,25 dihydroxy vitamin D3. Cell Tissue Res 1980; 209: 161-166.
  • 14. Wang J, Lv S, Chen G, Gao C, He J, Zhong H, Xu Y. Metaanalysis of the association between vitamin d and autoimmune thyroid disease. Nutrients 2015; 7: 2485-2498.
  • 15. Allan WC,  Haddow JE,  Palomaki GE,  Williams JR,  Mitchell ML, Hermos RJ, Faix JD, Klein RZ. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000; 7: 127-130.
  • 16. Goodwin TM. Hyperemesis gravidarum. Clin Obstet Gynecol 1998; 41: 597-605.
  • 17. d’Emden MC, Wark JD. Vitamin D-enhanced thyrotrophin release from rat pituitary cells: effects of Ca2+, dihydropyridines and ionomycin. J Endocrinol 1989; 121: 441-450.
  • 18. Kano K, Jones G. Direct in vitro effect of thyroid hormones on 25-hydroxyvitamin D3 metabolism in the perfused rat kidney. Endocrinology 1984; 114: 330-336.
  • 19. Mackawy AM, Al-Ayed BM, Al-Rashidi BM. Vitamin D deficiency and its association with thyroid disease. Int J Health Sci 2013; 7: 267-275.
  • 20. Yasuda T,  Okamoto Y,  Hamada N,  Miyashita K,  Takahara M,  Sakamoto F,  Miyatsuka T,  Kitamura T,  Katakami N, Kawamori D et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease. Endocrine 2012; 42: 739-741.
  • 21. Bouillon R, De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab 1980; 51: 793-797.
  • 22. MacFarlane I, Mawer E, Berry J, Hann J. Vitamin D metabolism in hyperthyroidism. Clin Endocrinol (Oxf) 1982; 17: 51- 59.
  • 23. Rosskamp R, Issa S, Burmeister W. Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1–44) in children. J Endocrinol Invest 1988; 11: 27-30.
  • 24. Zhou H, Xu C, Gu M. Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clin Endocrinol 2009; 70: 938-945.
  • 25. Orwoll E,  Nielson CM,  Marshall LM,  Lambert L,  Holton KF, Hoffman AR, Barrett-Connor E, Shikany JM, Dam T, Cauley JA. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009; 94: 1214-1222.
  • 26. Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.
  • 27. Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007; 103: 620-625.
  • 28. Hekimsoy Z,  Dinç G,  Kafesçiler S,  Onur E,  Güvenç Y,  Pala T, Güçlü F, Ozmen B. Vitamin D status among adults in the Aegean region of Turkey. BMC Public Health 2010; 10: 782.
  • 29. Davies-Tuck M, Yim C, Knight M, Hodges R, Doery JC, Wallace E. Vitamin D testing in pregnancy: does one size fit all? Aust N Z J Obstet Gynaecol 2015; 55: 149-155.
  • 30. Datta S, Alfaham M, Davies DP, Dunstan F, Woodhead S, Evans J,  Richards B. Vitamin D deficiency in pregnant women from a non-European ethnic minority population--an interventional study. BJOG 2002; 109: 905-908.
  • 31. Pehlivan I, Hatun S, Aydoğan M, Babaoğlu K, Gökalp AS. Maternal vitamin D deficiency and vitamin D supplementation in healthy infants. Turk J Pediatr 2003; 45: 315-320.
  • 32. Specker BL,  Valanis B,  Hertzberg V,  Edwards N,  Tsang RC. Sunshine exposure and serum 25-hydroxyvitamin D concentrations in exclusively breast-fed infants. J Pediatr 1985; 107: 372-376.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK